Materials and Methods

Chemicals and reagents
Compounds in the fragment library were purchased from Specs, additional structural neighbours were purchased from Specs and Enamine. O-(2-Acetamido-2-deoxy-D-glucopyranosylidene) amino-Z-Nphenylcarbamate (PUGNAc) was purchased from Tocris Bioscience.
The fragment library was assembled as described by Schulz et al. [1] and dissolved in DMSO-d6 to a concentration of 200 mM and quality controlled using 1 H NMR spectroscopy. Instant JChem 5.3.8, 2010, ChemAxon (http://www.chemaxon.com), was used for structure database management.
NMR spectroscopy and fragment screening
NMR experiments were carried out on a Bruker Avance II 700 MHz NMR spectrometer equipped with a triple resonance probe and z axis gradients. Data were processed using Topspin 3.2 software. Three NMR experiments were used for the screening, STD NMR, [2] PO-WaterLOGSY, [3] and T1ρ-filtered [4] 1 H NMR experiments. All NMR screening data were collected at 288K and the samples contained 20 μM BtGH84, fragments at a concentration of approximately 200 μM per compound and 20 μM of TSP in 25 mM phosphate buffer containing 150 mM NaCl and 10% D2O at pH 7.4. A single point titration by addition of PUGNAc was performed, giving a final PUGNAc concentration of 83 μM. The experiments were recorded using the standard STD NMR pulse sequence with a 15 ms 6 kHz spin-lock pulse to reduce the background protein resonances and excitation sculpting to suppress the water resonance. Saturation of the protein NMR signals of the enzyme were performed using a train of 70 selective 69 Hz Gaussian pulses with duration of 50 ms, adding up to a total saturation time of 3.5 s. The on-resonance frequency was set to 0.4 ppm and offresonance irradiation was applied at 80 ppm. STD NMR spectra were acquired with a total of 480 transients in addition to 16 scans to allow the sample to come to equilibrium. Spectra were performed with a sweep width of 16 ppm and 16k data points corresponding to an acquisition time of 0.7 s and with an additional relaxation delay of 0.1 s giving a total repetition time of 4.3 s for the experiment. The PO-WaterLOGSY experiments were set-up using the same pulse sequence and parameters as Gossert et al., [3] but with 128 transients, 32 'dummy' scans and a sweep width of 15 ppm. T1ρ filtered experiments were run with 32 transients, 16 'dummy' scans, a spin-lock pulse of 600 ms at 6 kHz and excitation sculpting to suppress the water resonance.
The affinity of the activator 2 was measured in the presence and absence of 200 μM PUGNAc, using a constant concentration of BtGH84 (8 μM), seven points of variable concentration of activator (0.07 -12.5 mM), the same buffer as for the screening and at 298 K. The transverse relaxation rates, R2, for the activator were measured at the different concentrations, using a CPMG pulse sequence with excitation sculpting to suppress the water resonance, 12 different spin-lock durations, 8-64 transients and a sweep width of 16 ppm. R2 values and Kds were then extracted using Sigmaplot.
Enzyme activity assay
AC50 measurements of fragment activators were performed using a fluorescent kinetic assay. Assays were carried out in a 96 well plate (Black Nunc F96 MicroWell Plates) at 25°C in a total volume of 100 μl per well, buffer (50 mM MES pH 6.5, 200 mM NaCl, 0.01% Tween-20, 1% DMSO) with 500 μM 4-methylumbelliferyl-β-D-GlcNAc (4MU-GlcNAc), as substrate and 50 nM BtGH84. Reactions were initiated by addition of 10 μl of substrate, to a final concentration of 500 μM, followed by 5 s of shaking. Fluorescent 4-methylumbelliferyl release was recorded continuously at 355 nm excitation and 460 nm emission for 20 s using a BMG PolarStar Optima plate reader. Rates were calculated using Sigmaplot as the slope of the curve of the collected data. Corrections were made to the detected gradients to adjust for the inner filter effect of 4MU-GlcNAc and convert the gradients into units of μmol min -1 according to a standard curve of 4MU. The initial slopes were fitted to four-parameter sigmoidal dose response curves using SigmaPlot and the AC50 values 
ITC
Isothermal titration calorimetry (ITC) measurements were carried out using a VC calorimeter (Microcal, Northampton, MA) at 25°C. BtGH84 was dialysed against 50 mM MES, pH 6.5, 200 mM NaCl, and concentrated to 70 and 100 μM for experiments with 10 mM and 0 mM of 2 respectively. Samples were centrifuged and degassed prior to use. PUGNAc was diluted in the same buffer to a final concentration of 0.8 respectively 1.2 mM and degassed. Titrations were performed by injection of 10 μL aliquots of the inhibitor into the BtGH84 solution. Using Microcal Origin software, the enthalpy for each injection was plotted against the molar ratio and fitted to a bimolecular model. The stoichiometry (n), enthalpy (ΔH), and association constant (Ka) were obtained from this fitting, and were used to calculate the Gibbs free energy (ΔG) and entropy (TΔS).
Crystallisation and structure determination
BtGH84 crystals were grown using the sitting-drop vapour diffusion method. 1 μl of 12 mg/ml BtGH84 was mixed with 1 μl of reservoir solution (0.1 M imidazole pH 8.0, 10% PEG8000 (w/v), 3% trimethylamine Noxide dehydrate, 12% ethylene glycol) and the crystals were allowed to grow at room temperature for at least 2 days. Crystal soaking was performed by gradually adding well solution containing 10 mM PUGNac and 50 mM activator 2, and 10% DMSO. Crystals were picked up with a nylon fibre loop (Hampton Research) and plunged into liquid nitrogen. Data were collected at Diamond beamline I04 using a Pilatus 6M-F detector (Dectris) at 100 K. An oscillation range of 0.1° degree was chosen and 180° were collected. Data were indexed, integrated and scaled using XDS. [5] Indexing was chosen to be consistent with previous collected data using Pointless [6] and a direct refinement of the model against the data was carried out. The model was improved and adjusted by alternating cycles of manual rebuilding and real-space refinement in COOT [7] and reciprocal-space refinement in Refmac [8] and Phenix. [9] Coordinate files and libraries for the ligand were created using phenix.eLBOW. [9] The quality of the final model was evaluated using the MolProbity-Server. [10] Figures were created using PyMol (Schrodinger LLC).
Differential scanning fluorimetry
DSF experiments were performed in 96-well polypropylene PCR plates (Agilent 401334) with a final well volume of 25 µl. Well components were BtGH84 (2 µM), Sypro Orange dye (2X), DMSO (2%), and compound at either 2, 4 or 8 mM dependent on solubility in the same buffer as used for the enzymatic assays. Melting data was collected using the Agilent Stratagene Mx3005P rtPCR machine ramping from 25°C to 95°C at 30 sec per degree. Data was analysed with a combination of the Agilent MxPro software, MTSA, [11] and the DSF analysis spreadsheet in Excel. [12] Human OGA expression Human OGA was expressed and purified in an analogous manner to that previously described by Macauley et al. [13] Supplementary figures Figure S1 : Chemical structures of hits identified from NMR-based fragment screening of BtGH84. The hits are divided into those competitive with the inhibitor PUGNAc (upper box) and those which were not competitive (lower box). Figure S2 . STD NMR spectrum of 2 (800 µM) with BtGH84 (8 µM) Figure S9: Effect of activators 2 and 4 on human OGA. Titration of the 4MU-GlcNAc substrate at pH 6.5.
Activators 2 and 4 do not appear to increase the activity of this enzyme.
Figure S10: Sequence alignment between catalytic domain of human OGA and BtGH84. Sequence alignment generated for the catalytic domains of BtGH84 and hOGA using the T-Coffee service (http://tcoffee.crg.cat/apps/tcoffee/index.html) and the figure generated with ESPript 3.0 (http://espript.ibcp.fr/ESPript/ESPript/) where identical residues are highlighted in red, similar residues in yellow, and secondary structure as arrows for beta sheet and a spring for a helix. The residue numbering is that for BtGH84. 
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